Press Release

Schrödinger to Present at Two Investor Healthcare Conferences in June

NEW YORK--(BUSINESS WIRE)--May 25, 2021-- Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that management will provide a corporate overview at the Jefferies Virtual Healthcare Conference on Tuesday, June 1, 2021, at 3:00 p.m. ET. Additionally, the company will present virtually at the Goldman Sachs 42nd Annual Global Healthcare Conference on Tuesday, June 8, 2021, at 4:40 p.m. ET.

The live webcasts can be accessed under "News & Events" in the investors section of Schrödinger’s website, and will be archived for approximately 14 days.

About Schrödinger

Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger’s multidisciplinary drug discovery team also leverages the software platform to advance collaborative programs and its own pipeline of novel therapeutics to address unmet medical needs.

Founded in 1990, Schrödinger has over 450 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit and follow us on LinkedIn and Twitter.

Jaren Irene Madden
Schrödinger, Inc.

Stephanie Simon (media)
Ten Bridge Communications

Source: Schrödinger

Back To Top